Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-03 7:25 pm Purchase | 2024-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | SABBY MANAGEMENT, LLC | 69,555 9.900% | 69,555 (New Position) | Filing History |
| 2024-11-06 4:05 pm Sale | 2024-09-30 | 13G | TransCode Therapeutics, Inc. RNAZ | 3i, LP | 0 0.000% | -52,018 (Position Closed) | Filing History |
| 2024-07-26 4:05 pm Purchase | 2024-07-23 | 13G | TransCode Therapeutics, Inc. RNAZ | 3i, LP | 52,018 9.900% | 52,018 (New Position) | Filing History |
| 2024-06-21 4:02 pm Purchase | 2024-06-14 | 13D | TransCode Therapeutics, Inc. RNAZ | Fitzgerald Thomas A | 12,789 5.500% | 12,789 (New Position) | Filing History |
| 2024-02-15 4:00 pm Purchase | 2023-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | Medarova Zdravka | 3,396 0.400% | 3,396 (New Position) | Filing History |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | TANG CAPITAL PARTNERS LP | 0 0.000% | -269 (Position Closed) | Filing History |
| 2024-02-13 8:12 pm Sale | 2023-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | Lind Global Fund II LP | 796 0.100% | -1,098 (-57.95%) | Filing History |
| 2023-12-07 4:30 pm Purchase | 2023-12-04 | 13G | TransCode Therapeutics, Inc. RNAZ | Lind Global Fund II LP | 1,894 9.900% | 1,894 (New Position) | Filing History |
| 2023-10-10 4:00 pm Purchase | 2023-09-28 | 13D | TransCode Therapeutics, Inc. RNAZ | Dudley Robert Michael | 173 1.900% | 88 (+104.19%) | Filing History |
| 2023-09-26 11:06 am Purchase | 2023-09-26 | 13G | TransCode Therapeutics, Inc. RNAZ | TANG CAPITAL PARTNERS LP | 269 9.990% | 269 (New Position) | Filing History |
| 2023-06-16 4:00 pm Purchase | 2023-06-09 | 13D | TransCode Therapeutics, Inc. RNAZ | Dudley Robert Michael | 84 6.000% | 84 (New Position) | Filing History |
| 2023-02-10 08:00 am Purchase | 2022-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | Medarova Zdravka | 63 12.700% | 2 (+2.61%) | Filing History |
| 2022-12-19 5:36 pm Purchase | 2022-10-01 | 13D | TransCode Therapeutics, Inc. RNAZ | Dudley Robert Michael | 67 12.700% | 12 (+22.54%) | Filing History |
| 2022-12-19 5:33 pm Purchase | 2021-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | Medarova Zdravka | 61 12.500% | 61 (New Position) | Filing History |
| 2022-12-19 5:32 pm Purchase | 2021-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | Dudley Robert Michael | 54 10.600% | 54 (New Position) | Filing History |
| 2022-10-27 08:08 am Sale | 2022-10-26 | 13G | TransCode Therapeutics, Inc. RNAZ | Orin Hirschman | 0 0.000% | -49 (Position Closed) | Filing History |
| 2022-02-11 3:06 pm Purchase | 2021-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | Orin Hirschman | 49 9.900% | 1 (+1.46%) | Filing History |
| 2021-07-20 5:55 pm Purchase | 2021-07-09 | 13G | TransCode Therapeutics, Inc. RNAZ | Orin Hirschman | 48 9.900% | 48 (New Position) | Filing History |